Profile: Strategic Diagnostics Inc (SDIX.O)
19 Jun 2013
Strategic Diagnostics Inc. (SDIX), incorporated on June 18, 1993, is a biotechnology company. The Company is engaged in developing, commercializing and marketing products and solutions that preserve human health and wellness. The Company's business is focused in two areas: Life Sciences and Kit Products. The Company's Food Safety portfolio includes immunoassays, which represent technology detection of food pathogens. SDIX's RapidChek and SELECT test kits are experiencing growing used for the detection of pathogens, such as E. coli, Salmonella and Listeria in the production, processing and manufacturing of food. The Company serves the pharmaceutical, biotechnology, diagnostics and food safety markets. In December 2011, Modern Water Plc acquired the water quality division of Strategic Diagnostics Inc.
The Company provides a range of life sciences products and services, including custom antibodies, in-vitro diagnostic-grade antibodies, proprietary critical reagent products, associated bio-processing services, and custom assay design and development services. The Company’s products and services are sold to, and often embedded in other products used by a range of customers, including pharmaceutical, biotechnology and diagnostic companies, and biomedical research centers both domestically and internationally. The Company’s detection technologies, enable industrial customers to identify the presence of adulterants, such as chemical toxins, biological pathogens and other contaminants. Many of the Company’s products are in the form of single use test devices, sample prep materials and reagents. An immunoassay is an analytical test that uses antibodies to detect the presence of a target in a complex biological sample.
The Company offers its services to the in-vitro diagnostic (IVD) market. Products and services include: analyte specific reagents, custom manufacturing of antibodies (monoclonal and polyclonal) and calibrators, and consultation for immunoassay design. The Company's products are suitable for use in a range of immunoassay formats, including lateral flow devices (LFD) and agglutination assays. The Company's offerings for this market are focused on two major areas: readymade antibodies and other reagents for immunoassays, and custom contract manufacturing of monoclonal and polyclonal antibodies. During the year ended December 31, 2011, the Company launched four new polyclonal antibodies, which include Apo B, IgA, HPT and C3.
Many of the Company's products are in the form of single use test devices, sample prep materials and reagents, thus creating recurring revenue opportunities. The Company’s industry applications include food and beverage manufacturing, and agriculture and agro-science.
Food Safety Products
The Company's food safety product line includes enrichment media and rapid tests to detect food pathogens, including E. coli O157 (including H7), Listeria and Salmonella. The Company is a supplier of tests for targeted traits in genetically engineered plants, tests to detect Genetically Modified (GM) traits in grain, seeds, food ingredients and food fractions and tests to detect naturally occurring fungi in grains (mycotoxins). The Company is applying its bacteriophage technology in its test kit products for the detection of bacterial food pathogens, including its Salmonella SELECT product.
The Company competes with Agdia, Envirologix, bioMerieux SA, BioControl Systems, Inc., DuPont Qualicon, Neogen Corp., 3M Company, BioControl Systems, Inc., Covance, Harlan, Lampire and Scantibodies.
Strategic Diagnostics Inc
111 Pencader Drive
NEWARK DE 19702